172 related articles for article (PubMed ID: 7893727)
21. Myocardial adaptation to creatine deficiency in rats fed with beta-guanidinopropionic acid, a creatine analogue.
Mekhfi H; Hoerter J; Lauer C; Wisnewsky C; Schwartz K; Ventura-Clapier R
Am J Physiol; 1990 Apr; 258(4 Pt 2):H1151-8. PubMed ID: 2184680
[TBL] [Abstract][Full Text] [Related]
22. Creatine kinase kinetics, ATP turnover, and cardiac performance in hearts depleted of creatine with the substrate analogue beta-guanidinopropionic acid.
Shoubridge EA; Jeffry FM; Keogh JM; Radda GK; Seymour AM
Biochim Biophys Acta; 1985 Oct; 847(1):25-32. PubMed ID: 4052460
[TBL] [Abstract][Full Text] [Related]
23. Intramitochondrial inclusions caused by depletion of creatine in rat skeletal muscles.
Ohira Y; Kanzaki M; Chen CS
Jpn J Physiol; 1988; 38(2):159-66. PubMed ID: 3172576
[TBL] [Abstract][Full Text] [Related]
24. Effect of a short-term dietary creatine supplementation on high-energy phosphates in the rat myocardium.
Brzezińska Z; Nazar K; Kaciuba-Uściłko H; Falecka-Wieczorek I; Wójcik-Ziółkowska E
J Physiol Pharmacol; 1998 Dec; 49(4):591-5. PubMed ID: 10069699
[TBL] [Abstract][Full Text] [Related]
25. AMP kinase is required for mitochondrial biogenesis in skeletal muscle in response to chronic energy deprivation.
Zong H; Ren JM; Young LH; Pypaert M; Mu J; Birnbaum MJ; Shulman GI
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):15983-7. PubMed ID: 12444247
[TBL] [Abstract][Full Text] [Related]
26. Cytochrome c mRNA and alpha-actin mRNA in muscles of rats fed beta-GPA.
Lai MM; Booth FW
J Appl Physiol (1985); 1990 Sep; 69(3):843-8. PubMed ID: 2174029
[TBL] [Abstract][Full Text] [Related]
27. Creatine analogue beta-guanidinopropionic acid alters skeletal muscle AMP deaminase activity.
Tullson PC; Rundell KW; Sabina RL; Terjung RL
Am J Physiol; 1996 Jan; 270(1 Pt 1):C76-85. PubMed ID: 8772432
[TBL] [Abstract][Full Text] [Related]
28. Adaptation of rat skeletal muscle to creatine depletion: AMP deaminase and AMP deamination.
Ren JM; Holloszy JO
J Appl Physiol (1985); 1992 Dec; 73(6):2713-6. PubMed ID: 1490990
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of endurance training and creatine depletion on regional mitochondrial adaptations in rat skeletal muscle.
Roussel D; Lhenry F; Ecochard L; Sempore B; Rouanet JL; Favier R
Biochem J; 2000 Sep; 350 Pt 2(Pt 2):547-53. PubMed ID: 10947970
[TBL] [Abstract][Full Text] [Related]
30. The acute effects of the creatine analogue, beta-guanidinopropionic acid, on cardiac energy metabolism and function.
Unitt JF; Radda GK; Seymour AM
Biochim Biophys Acta; 1993 Jun; 1143(1):91-6. PubMed ID: 8499456
[TBL] [Abstract][Full Text] [Related]
31. Theoretical modelling of some spatial and temporal aspects of the mitochondrion/creatine kinase/myofibril system in muscle.
Kemp GJ; Manners DN; Clark JF; Bastin ME; Radda GK
Mol Cell Biochem; 1998 Jul; 184(1-2):249-89. PubMed ID: 9746325
[TBL] [Abstract][Full Text] [Related]
32. Age-dependent changes in cardiac muscle metabolism upon replacement of creatine by beta- guanidinopropionic acid.
Field ML; Unitt JF; Radda GK; Henderson C; Seymour AM
Biochem Soc Trans; 1991 Apr; 19(2):208S. PubMed ID: 1889584
[No Abstract] [Full Text] [Related]
33. Phosphorylated beta-guanidinopropionate as a substitute for phosphocreatine in rat muscle.
Fitch CD; Jellinek M; Fitts RH; Baldwin KM; Holloszy JO
Am J Physiol; 1975 Apr; 228(4):1123-5. PubMed ID: 1130513
[TBL] [Abstract][Full Text] [Related]
34. The effect of the creatine analogue beta-guanidinopropionic acid on energy metabolism: a systematic review.
Oudman I; Clark JF; Brewster LM
PLoS One; 2013; 8(1):e52879. PubMed ID: 23326362
[TBL] [Abstract][Full Text] [Related]
35. The induction of mitochondrial myopathy in the rat by feeding beta-guanidinopropionic acid and the reversibility of the induced mitochondrial lesions: a biochemical and ultrastructural investigation.
De Tata V; Cavallini G; Pollera M; Gori Z; Bergamini E
Int J Exp Pathol; 1993 Oct; 74(5):501-9. PubMed ID: 8217785
[TBL] [Abstract][Full Text] [Related]
36. Experimental depletion of creatine and phosphocreatine from skeletal muscle.
Fitch CD; Jellinek M; Mueller EJ
J Biol Chem; 1974 Feb; 249(4):1060-3. PubMed ID: 4814337
[No Abstract] [Full Text] [Related]
37. What is the trigger mechanism for changes of the oxidative potential in skeletal muscle?
Nemirovskaya TL; Shenkman BS; Mayevsky EI; Grishina E
J Gravit Physiol; 1998 Jul; 5(1):P79-80. PubMed ID: 11542374
[TBL] [Abstract][Full Text] [Related]
38. Bioenergetic consequences of cardiac phosphocreatine depletion induced by creatine analogue feeding.
Zweier JL; Jacobus WE; Korecky B; Brandejs-Barry Y
J Biol Chem; 1991 Oct; 266(30):20296-304. PubMed ID: 1939088
[TBL] [Abstract][Full Text] [Related]
39. Thyroid hormone regulation of cardiac bioenergetics: role of intracellular creatine.
Queiroz MS; Shao Y; Berkich DA; Lanoue KF; Ismail-Beigi F
Am J Physiol Heart Circ Physiol; 2002 Dec; 283(6):H2527-33. PubMed ID: 12427598
[TBL] [Abstract][Full Text] [Related]
40. Mitochondrial myopathy in rats fed with a diet containing beta-guanidine propionic acid, an inhibitor of creatine entry in muscle cells.
Gori Z; De Tata V; Pollera M; Bergamini E
Br J Exp Pathol; 1988 Oct; 69(5):639-50. PubMed ID: 3196657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
